{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:01:00Z","timestamp":1762999260094},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijcard.2017.03.051","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T23:05:13Z","timestamp":1489446313000},"page":"92-96","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: A 1-year follow-up study"],"prefix":"10.1016","volume":"238","author":[{"given":"Diana","family":"Rinkuniene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ausra","family":"Krivickiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Laukaitiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaldas","family":"Jurkevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.03.051_bb0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jacc.2004.03.054","article-title":"Long-term retention of cardiac resynchronization therapy","volume":"44","author":"Knight","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2017.03.051_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2005.03.078","article-title":"Management of heart failure after cardiac resynchronization therapy integrating advanced heart failure treatment with optimal device function","volume":"46","author":"Aranda","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure, SOLVD investigators","volume":"86","author":"Konstam","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0020","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.CIR.88.5.2277","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) investigators","volume":"88","author":"Konstam","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0025","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1067\/mhj.2000.105302","article-title":"Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy","volume":"139","author":"Konstam","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0030","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1161\/CIRCULATIONAHA.104.508093","article-title":"Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction","volume":"111","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0735-1097(97)00012-0","article-title":"Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease, Australia-New Zealand Heart Failure Research Collaborative Group","volume":"29","author":"Doughty","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0040","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2003.12.053","article-title":"Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan Heart Failure Trial (Val-HeFT) echocardiographic data","volume":"43","author":"Wong","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0045","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/eurheartj\/eht160","article-title":"Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study","volume":"34","author":"Linde","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0050","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/europace\/eus152","article-title":"Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy","volume":"14","author":"Kreuz","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0055","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/clc.20500","article-title":"Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy","volume":"33","author":"Voigt","year":"2010","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/JAHA.111.000018","article-title":"Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF","volume":"1","author":"Fonarow","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1388-9842(01)00198-2","article-title":"The current cost of heart failure to the National Health Service in the UK","volume":"4","author":"Stewart","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejheart.2005.07.003","article-title":"Exploring symptoms in chronic heart failure","volume":"7","author":"Ekman","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0735-1097(93)90816-J","article-title":"Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure, principal investigators of the REFLECT study","volume":"22","author":"Packer","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0167-5273(89)90010-7","article-title":"Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study","volume":"24","author":"Cowley","year":"1989","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2017.03.051_bb0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0090","doi-asserted-by":"crossref","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet 353 (9146), 1999, 9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0095","doi-asserted-by":"crossref","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF), Lancet 353 (9169), 1999, 2001\u20132007.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF), MERIT-HF study group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0110","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/eurheartj\/eht514","article-title":"Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy","volume":"35","author":"Schmidt","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1460-9592.2003.00011.x","article-title":"Is the outcome of cardiac resynchronization therapy related to the underlying etiology?","volume":"26","author":"Gasparini","year":"2003","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0735-1097(02)01970-8","article-title":"Dose of metoprolol CR\/XL and clinical outcomes in patients with heart failure: analysis of the experience in Metoprolol CR\/XL Randomized Intervention Trial in Chronic Heart Failure (MERITHF)","volume":"40","author":"Wikstrand","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0130","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.amjcard.2004.12.023","article-title":"Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration","volume":"95","author":"Aranda","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0135","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/AC.66.5.2131081","article-title":"Cardiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study","volume":"66","author":"Grosu","year":"2011","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0145","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0150","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.99.12.1567","article-title":"Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay","volume":"99","author":"Kass","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.051_bb0155","unstructured":"P. Bertram. Heart failure: the role for mineralocorticoid receptor antagonists, Medical intelligence|published 20 May 2014, Cite this as: Swiss Med Wkly, 2014;144:w13959."},{"key":"10.1016\/j.ijcard.2017.03.051_bb0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0033-0620(96)80018-1","article-title":"Antithrombotic therapy in atrial fibrillation: a review of randomized trials with special reference to the Stroke Prevention in Atrial Fibrillation II (SPAF II) trial","volume":"38","author":"Shivkumar","year":"1996","journal-title":"Prog. Cardiovasc. Dis."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317316108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317316108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T13:50:37Z","timestamp":1568901037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317316108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"alternative-id":["S0167527317316108"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.051","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: A 1-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}